Our latest
Creative Biosciences
Creative Biosciences Expands in Latin America, Bringing Colosafe® Closer to Local Communities for Early Cancer Detection

Guangzhou, China — October 30, 2025 — Creative Biosciences is accelerating its global growth by expanding across Latin America through new strategic partnerships and the regional introduction of its flagship product, Colosafe®, a noninvasive stool DNA tes

Nov 02 , 2025
Media Coverage
Authoritative media releases


Press releases
Creative Biosciences Expands in Latin America, Bringing Colosafe® Closer to Local Communities for Early Cancer Detection
Nov 02 , 2025
Lunsafe® Wins NMPA Approval, Pioneering Noninvasive Early Detection of Lung Cancer in China
Jun 01 , 2025
Creativebio Made Debut Presence at Life Science Innovation Northwest 2025
May 06 , 2025
Creative Biosciences Expands Global Footprint with New Seattle Branch
Mar 21 , 2025
One Million Tests of Colosafe Realized in Real World Practice
Feb 20 , 2025
CreativeBio Is Exhibiting at MEDICA 2022
Nov 15 , 2022
Colosafe® Gained Market Entry in Mexico
Jan 23 , 2025
CreativeBio,the Leading Enterprise in Cancer Screening,Completed Rd D Venture Capital Financing of RMB 560 Million Led by Alibaba
Oct 20 , 2021
Creative Biosciences Shines at MEDICA 2024 in Germany, Accelerating Its Global Market Expansion
Nov 14 , 2024
Colosafe Was Showcased at the 46th Mexican National Clinical Chemists Conference in Mecixo City
Sep 15 , 2024
Colosafe® Showcased in the National "13th Five-Year" Scientific and Technical Innovation Achievement Exhibition
Nov 02 , 2021
Marvelous News! Creative Biosciences Won the National-Level Title of "Little Giant" Enterprise in the Category of Specialization, Refinement, Differentiation, and Innovation.
Sep 07 , 2024